Olink Proteomics AB:企業の製品パイプライン分析

◆英語タイトル:Olink Proteomics AB - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME196256PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥199,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥299,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Olink Proteomics AB (Olink) is a biotechnology company that offers products and services for human protein biomarker research. The company provides portfolio of products such as biomarkers, cardiovascular diseases panels, neurological disease panels, inflammation panels and oncology panels. Olink through its Proximity Extension Assay (PEA) technology develops multiplex immunoassay panels for human protein biomarker research. It works in collaboration with other organizations to develop new projects. The company through Olink Bioscience focuses on the development and commercialization of enabling molecular tools for life science research and molecular diagnostics. It also provides protein biomarker discovery data analysis services in Watertown and Sweden. The company also has operational presence in the US. Olink is headquartered in Uppsala, Sweden.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Olink Proteomics AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Olink Proteomics AB Company Overview
Olink Proteomics AB Company Snapshot
Olink Proteomics AB Pipeline Products and Ongoing Clinical Trials Overview
Olink Proteomics AB – Pipeline Analysis Overview
Olink Proteomics AB – Key Facts
Olink Proteomics AB – Major Products and Services
Olink Proteomics AB Pipeline Products by Development Stage
Olink Proteomics AB Pipeline Products Overview
Blood Test – Diagnostic Purposes
Blood Test – Diagnostic Purposes Product Overview
Blood Test – Ovarian Cancer
Blood Test – Ovarian Cancer Product Overview
cJun-Smad 2/3 Kit
cJun-Smad 2/3 Kit Product Overview
Companion Diagnostic Assay – Aromatase
Companion Diagnostic Assay – Aromatase Product Overview
Companion Diagnostic Assay – Trastuzumab
Companion Diagnostic Assay – Trastuzumab Product Overview
HER2-pEGFR Kit
HER2-pEGFR Kit Product Overview
s100A4 Kit
s100A4 Kit Product Overview
U-Rhythm Device
U-Rhythm Device Product Overview
Olink Proteomics AB – Key Competitors
Olink Proteomics AB – Key Employees
Olink Proteomics AB – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Olink Proteomics AB, Recent Developments
Jun 21, 2019: Breakthrough biomarker blood test for ovarian cancer on the horizon
Aug 30, 2018: Olink Proteomics announces a new biomarker panel that expands its protein library to over 1000 high-quality assays
Dec 14, 2017: Olink Proteomics announces the availability of the most comprehensive, high-multiplex protein biomarker panel for mouse studies
Feb 16, 2017: Olink Proteomics announces the availability of three new biomarker panels focused on key biological processes with broad clinical relevance
Nov 29, 2016: Olink Proteomics announces the availability of three new biomarker panels to further explore the complexities of the human proteome
Sep 21, 2016: Olink Proteomics announces the availability of the broadest and most complete protein biomarker panel for immuno-oncology
Apr 12, 2016: Focusing for success: A new Olink company organization to meet our future ambitions
Jan 27, 2016: Olink Bioscience introduces a new precision proteomics solution for neurology
Oct 06, 2015: Olink Bioscience introduces two new 92 – protein biomarker panels for cardiovascular disease research
Jul 01, 2014: Olink Bioscience introduces a 92 – protein biomarker panel for inflammatory diseases
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Olink Proteomics AB Pipeline Products and Ongoing Clinical Trials Overview
Olink Proteomics AB Pipeline Products by Equipment Type
Olink Proteomics AB Pipeline Products by Indication
Olink Proteomics AB, Key Facts
Olink Proteomics AB, Major Products and Services
Olink Proteomics AB Number of Pipeline Products by Development Stage
Olink Proteomics AB Pipeline Products Summary by Development Stage
Blood Test - Diagnostic Purposes - Product Status
Blood Test - Diagnostic Purposes - Product Description
Blood Test - Ovarian Cancer - Product Status
Blood Test - Ovarian Cancer - Product Description
cJun-Smad 2/3 Kit - Product Status
cJun-Smad 2/3 Kit - Product Description
Companion Diagnostic Assay - Aromatase - Product Status
Companion Diagnostic Assay - Aromatase - Product Description
Companion Diagnostic Assay - Trastuzumab - Product Status
Companion Diagnostic Assay - Trastuzumab - Product Description
HER2-pEGFR Kit - Product Status
HER2-pEGFR Kit - Product Description
s100A4 Kit - Product Status
s100A4 Kit - Product Description
U-Rhythm Device - Product Status
U-Rhythm Device - Product Description
Olink Proteomics AB, Key Employees
Olink Proteomics AB, Other Locations
Olink Proteomics AB, Subsidiaries
Glossary

★海外企業調査レポート[Olink Proteomics AB:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pentax Europe GmbH-医療機器分野:企業M&A・提携分析
    Summary Pentax Europe GmbH (Pentax Medical), a subsidiary of Hoya Corp is a medical device company that provides clinical endo-imaging solutions. The company offers products in the therapeutic areas of gastroenterology, endoscopic ultrasound, ENT and speech, pulmonology, and urology. Its products in …
  • Gunvor Group Ltd:企業の戦略的SWOT分析
    Gunvor Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Semcon AB (SEMC):企業の財務・戦略的SWOT分析
    Summary Semcon AB (Semcon) is a technology company that offers product design and information services. The company’s services include production development, project management, designing, product development, and product information. Its designing services comprise visualization, industrial design …
  • SPX Corp (SPXC):電力:M&Aディール及び事業提携情報
    Summary SPX Corp (SPX) is a specialized engineered solutions provider. It offers highly engineered products, technologies, and solutions. The company’s portfolio includes heating, ventilation, and air conditioning (HVAC) products, detection and measurement equipment, and engineered solutions. It off …
  • Ferguson Plc:企業のM&A・事業提携・投資動向
    Ferguson Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ferguson Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • PAL Holdings, Inc.:企業の戦略・SWOT・財務情報
    PAL Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary PAL Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cura Healthcare Pvt Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Cura Healthcare Pvt Ltd (Cura Healthcare) is a medical device company that offers imaging products. The company offers product portfolio such as imaging, ultrasound, women’s health, cardiology, anesthesia, critical care and OT; and nephrology products, among others. Cura Healthcare provides …
  • NBCUniversal Media LLC:企業の戦略・SWOT・財務情報
    NBCUniversal Media LLC - Strategy, SWOT and Corporate Finance Report Summary NBCUniversal Media LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Escher Group Holdings plc:企業の戦略・SWOT・財務情報
    Escher Group Holdings plc - Strategy, SWOT and Corporate Finance Report Summary Escher Group Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Blue Label Telecoms Ltd (BLU):企業の財務・戦略的SWOT分析
    Blue Label Telecoms Ltd (BLU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Uni-President China Holdings Ltd
    Uni-President China Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Uni-President China Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Quest Diagnostics Incorporated:企業のM&A・事業提携・投資動向
    Quest Diagnostics Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Quest Diagnostics Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • SilverSun Technologies Inc (SSNT):企業の財務・戦略的SWOT分析
    Summary SilverSun Technologies Inc (SilverSun) is a technology company that offers transformational business technology solutions and services for manufacturers and distributors. The company’s ERP software products comprise ERP X3, MAS90 and MAS200. It offers network services such as 24/7 remote net …
  • RespireRx Pharmaceuticals Inc (RSPI):製薬・医療:M&Aディール及び事業提携情報
    Summary RespireRx Pharmaceuticals Inc (RespireRx), formerly Cortex Pharmaceuticals, Inc., focuses on the discovery, development and commercialization of innovative products for the treatment of various respiratory disorders. It has two drug platforms, each with a clinical stage compound directed at …
  • Banque Internationale à Luxembourg SA:企業の戦略・SWOT・財務情報
    Banque Internationale à Luxembourg SA - Strategy, SWOT and Corporate Finance Report Summary Banque Internationale à Luxembourg SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Revolution Lighting Technologies Inc (RVLT):企業の財務・戦略的SWOT分析
    Revolution Lighting Technologies Inc (RVLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Lockheed Martin Aeronautics Company:企業の戦略・SWOT・財務情報
    Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Euticals SpA-製薬・医療分野:企業M&A・提携分析
    Summary Euticals SpA (Euticals) is a chemical company that develops and supplies active pharmaceutical ingredients, fine chemicals and contract manufacturing. The company possess technologies and capabilities in the domains of fermentation and enzymatic chemistry; boronic acids, biaryls, grignards a …
  • BE Semiconductor Industries N.V. (BESI):企業の財務・戦略的SWOT分析
    BE Semiconductor Industries N.V. (BESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Clean Energy Finance Corp:電力:M&Aディール及び事業提携情報
    Summary Clean Energy Finance Corp (CEFC) is a statutory authority that provides investments for clean energy projects including renewable energy, energy efficiency and low emissions technologies. The authority financing structures include project finance, climate bonds and equity funds, aggregation …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆